某肿瘤专科医院抗肿瘤药致不良反应报告309例分析
x

请在关注微信后,向客服人员索取文件

篇名: 某肿瘤专科医院抗肿瘤药致不良反应报告309例分析
TITLE:
摘要: 目的:了解抗肿瘤药致药品不良反应(ADR)的特点和发生规律,为临床安全使用抗肿瘤药提供参考。方法:采用回顾性研究方法,对某肿瘤专科医院2015年1-12月收集的309例抗肿瘤药致ADR报告进行统计、分析。结果:309例ADR患者中,女性(58.25%)多于男性(41.75%);40岁以上患者所占比例较高(78.64%);引发ADR的给药途径以静脉滴注为主(94.82%);严重的ADR 225例(72.82%);经停药或治疗后好转的有268例(86.73%)。309例ADR共涉及24种抗肿瘤药物,引发ADR最多的药品依次为多西他赛、顺铂和环磷酰胺;ADR累及器官/系统以造血系统最常见(64.24%),临床表现主要为骨髓抑制。结论:临床应加强抗肿瘤药的ADR监测,及时预防、发现和诊治抗肿瘤药引发的ADR,以减少对患者造成的伤害,保证药物治疗的安全、有效。
ABSTRACT: OBJECTIVE: To investigate the characteristic and regularity of antineoplastics-induced ADR, and to provide reference for safety use of antineoplastics in clinic. METHODS: In retrospective study, 309 cases of antineoplastics-induced ADR collected from a special hospital during Jan.-Dec. 2015 were summarized and analyzed statistically. RESULTS: Among 309 ADR cases, female (58.25%) was more than male (41.75%). The patients aged more than 40 years old occupied the highest proportion (78.64%). Main route of administration was intravenous dripping (94.82%). There were 225 cases of severe ADR (72.82%). Total 268 cases were improved after drug withdrawal or treatment (86.73%). A total of 24 kinds of antineoplastics were involved in 309 ADR cases; most of ADR were induced by docetaxel, followed by cisplatin, cyclophosphamide. Most common organs/system involved in ADR was hemopoietic system (64.24%), main clinical manifestation was myelosuppression. CONCLUSIONS: It is necessary to strengthen ADR monitoring, prevent, discover and treat antineoplastics-induced ADR timely, in order to reduce the harm to the patients and ensure the safety and effectiveness of drug treatment.
期刊: 2017年第28卷第26期
作者: 潘文,李豫,黄天文,雷宇,梁琳琳
AUTHORS: PAN Wen,LI Yu,HUANG Tianwen,LEI Yu,LIANG Linlin
关键字: 抗肿瘤药;药品不良反应;回顾性分析
KEYWORDS: Antineoplastics; ADR; Retrospective analysis
阅读数: 281 次
本月下载数: 3 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!